Rankings
▼
Calendar
AMRN FY 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$229M
+26.6% YoY
Gross Profit
$175M
76.2% margin
Operating Income
-$108M
-47.2% margin
Net Income
-$116M
-50.8% margin
EPS (Diluted)
$-7.80
Cash Flow
Operating Cash Flow
-$95M
Free Cash Flow
-$95M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$386M
Total Liabilities
$233M
Stockholders' Equity
$152M
Cash & Equivalents
$249M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$229M
$181M
+26.6%
Gross Profit
$175M
$136M
+28.3%
Operating Income
-$108M
-$46M
-137.6%
Net Income
-$116M
-$68M
-71.6%
← Q4 2017
All Quarters
Q1 2018 →